Health Care & Life Sciences » Pharmaceuticals | Rohto Pharmaceutical Co. Ltd.

Rohto Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
14,599
13,751
14,303
14,752
16,820
16,300
Depreciation, Depletion & Amortization
5,926
6,341
6,448
5,923
5,914
6,404
Other Funds
21
48
34
20
57
1,500
Funds from Operations
19,786
16,987
19,711
15,187
19,695
21,206
Changes in Working Capital
1,125
5,695
8,387
1,759
541
539
Net Operating Cash Flow
18,661
11,292
11,324
13,428
19,154
21,745
Capital Expenditures
6,709
4,147
4,731
3,980
5,452
Purchase/Sale of Investments
3,053
466
197
5,099
5,236
Net Investing Cash Flow
12,620
9,024
6,066
9,511
11,014
Cash Dividends Paid - Total
2,116
2,050
2,278
2,278
2,506
Issuance/Reduction of Debt, Net
2,245
1,611
3,899
305
737
Net Financing Cash Flow
5,211
3,375
5,898
2,335
1,823
Net Change in Cash
2,678
1,667
2,638
949
6,126
Free Cash Flow
12,383
7,328
6,761
9,651
14,154
Net Assets from Acquisitions
760
3,836
-
-
-
Other Sources
200
-
-
297
47
Change in Capital Stock
5,319
334
245
268
3
Exchange Rate Effect
1,848
2,774
1,998
633
191
Other Uses
2,298
575
1,138
730
373

About Rohto Pharmaceutical Co.

View Profile
Address
1-8-1 Tatsumi-nishi
Osaka Osaka 544
Japan
Employees -
Website http://www.rohto.co.jp
Updated 07/08/2019
Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others.